Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: A role for granule components

Haematologica

Volumn 101, Issue 5, 2016, Pages 587-596

  Gazendam, Roel P ^a   van de Geer, Annemarie ^a   van Hamme, John L ^a   Tool, Anton T J ^a   van Rees, Dieke J ^a   Aarts, Cathelijn E M ^a   van den Biggelaar, Maartje ^a   van Alphen, Floris ^a   Verkuijlen, Paul ^a   Meijer, Alexander B ^a   Janssen, Hans ^b   Roos, Dirk ^a   van den Berg, Timo K ^a   Kuijpers, Taco W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ADENYLYL CYCLASE ASSOCIATED PROTEIN 1; DEXAMETHASONE; EOSINOPHIL PEROXIDASE; GRANCALCIN; GRANULOCYTE COLONY STIMULATING FACTOR; MAJOR BASIC PROTEIN; MEMBRANE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PEPTIDOGLYCAN RECOGNITION PROTEIN; POLYADENYLIC ACID BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERINE ARGININE RICH SPLICING FACTOR; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN 8; BIOLOGICAL MARKER;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELL ISOLATION; CONTROLLED STUDY; DEGRANULATION ASSAY; FLOW CYTOMETRY; GRANULOCYTE TRANSFUSION; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MTT ASSAY; NEUTROPHIL MEDIATED CYTOTOXIC RESPONSE; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; CELL GRANULE; CYTOTOXICITY; DEGRANULATION; DRUG EFFECTS; GRANULOCYTE; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE TRANSFUSION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; NEUTROPHIL;

BIOMARKERS; CANDIDA ALBICANS; CELL DEGRANULATION; CYTOPLASMIC GRANULES; CYTOTOXICITY, IMMUNOLOGIC; DEXAMETHASONE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTE TRANSFUSION; MICROBIAL VIABILITY; NADPH OXIDASE; NEUTROPHILS; PHAGOCYTOSIS; PHAGOSOMES;

EID: 84964766156     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.136630     Document Type: Article

References (42)

1. Denning DW, Bromley MJ. Infectious Disease. How to bolster the antifungal pipeline. Science. 2015;347(6229):1414-1416.
2. Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172-1177.
3. Johnston DL, Lewis V, Yanofsky R, et al. Invasive fungal infections in paediatric acute myeloid leukaemia. Mycoses. 2013;56(4):482-487.
4. Drewniak A, Kuijpers TW. Granulocyte transfusion therapy: randomization after all? Haematologica. 2009;94(12):1644-1648.
5. Marfin AA, Price TH. Granulocyte Transfusion Therapy. J Intensive Care Med. 2013;30(2):79-88.
6. Drewniak A, van Raam BJ, Geissler J, et al. Changes in gene expression of granulocytes during in vivo granulocyte colony-stimulating factor/dexamethasone mobilization for transfusion purposes. Blood. 2009; 113(23):5979-5998.
7. Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol. 2011;29:1-21.
8. Gazendam RP, van Hamme JL, Tool AT, et al. Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood. 2014;124(4):590-597.
9. Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun. 1987;144(3):1143-1146.
10. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis. 1991;163(3):579-583.
11. Nohmi T, Abe S, Tansho S, Yamaguchi H. Suppression of anti-Candida activity of murine and human neutrophils by glucocorticoids. Microbiol Immunol. 1994; 38(12):977-982.
12. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ. Prevention of corticosteroidinduced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun. 1993; 61(11):4870-4877.
13. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion. 1998; 38(8):713-721.
14. Drewniak A, Boelens JJ, Vrielink H, et al. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes. Haematologica. 2008;93(7):1058-1067.
15. Mochizuki K, Kikuta A, Ohto H, et al. Extended storage of granulocyte concentrates mobilized by G-CSF with/without dexamethasone and collected by bag separation method. Transfus Med. 2007; 17(4):296-303.
16. van Raam BJ, Drewniak A, Groenewold V, van den Berg TK, Kuijpers TW. Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3. Blood. 2008;112(5):2046-2054.
17. Leavey PJ, Sellins KS, Thurman G, et al. In vivo treatment with granulocyte colonystimulating factor results in divergent effects on neutrophil functions measured in vitro. Blood. 1998;92(11):4366-4374.
18. Borregaard N, Sehested M, Nielsen BS, Sengelov H, Kjeldsen L. Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood. 1995;85(3):812-817.
19. Zarember KA, Sugui JA, Chang YC, Kwon-Chung KJ, Gallin JI. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrinmediated iron depletion. J Immunol. 2007;178(10):6367-6373.
20. Gabay JE, Scott RW, Campanelli D, et al. Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci USA. 1989;86(14):5610-5614.
21. Lehrer RI. Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest. 1972;51 (10):2566-2572.
22. Drewniak A, Gazendam RP, Tool AT, et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood. 2013;121(13):2385-2392.
23. Liles WC, Rodger E, Dale DC. Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: optimization of dosing. Transfusion. 2000;40(6):642-644.
24. Devi S, Wang Y, Chew WK, et al. Neutrophil mobilization via plerixaformediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow. J Exp Med. 2013;210(11):2321-2336.
25. Kumamoto CA, Vinces MD. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol. 2005;7(11):1546-1554.
26. Kinchen JM, Ravichandran KS. Phagosome maturation: going through the acid test. Nat Rev Mol Cell Biol. 2008;9(10):781-795.
27. Zhao XW, Gazendam RP, Drewniak A, et al. Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations. Blood. 2013;122(1):109-111.
28. Lonnbro P, Nordenfelt P, Tapper H. Isolation of bacteria-containing phagosomes by magnetic selection. BMC Cell Biol. 2008;9:35.
29. Jiang S, Park DW, Tadie JM, et al. Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury. J Immunol. 2014;192(10): 4795-4803.
30. Jones LC, Moussa L, Fulcher ML, et al. VAMP8 is a vesicle SNARE that regulates mucin secretion in airway goblet cells. J Physiol. 2012;590(Pt 3):545-562.
31. van EM, van Roomen CP, Renkema GH, et al. Characterization of human phagocytederived chitotriosidase, a component of innate immunity. Int Immunol. 2005;17 (11):1505-1512.
32. Xu P, Roes J, Segal AW, Radulovic M. The role of grancalcin in adhesion of neutrophils. Cell Immunol. 2006;240(2):116-121.
33. Pizon V, Desjardins M, Bucci C, Parton RG, Zerial M. Association of Rap1a and Rap1b proteins with late endocytic/phagocytic compartments and Rap2a with the Golgi complex. J Cell Sci. 1994;107(Pt 6):1661-1670.
34. Yokoyama K, Kaji H, He J, et al. Rab27a negatively regulates phagocytosis by prolongation of the actin-coating stage around phagosomes. J Biol Chem. 2011;286(7): 5375-5382.
35. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol. 1989;142(12):4428-4434.
36. Plager DA, Loegering DA, Weiler DA, et al. A novel and highly divergent homolog of human eosinophil granule major basic protein. J Biol Chem. 1999;274(20):14464-14473.
37. Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11 (8):783-784.
38. Rex JH, Bennett JE, Gallin JI, Malech HL, Melnick DA. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis. 1990;162(2):523-528.
39. Rorvig S, Ostergaard O, Heegaard NH, Borregaard N. Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors. J Leukoc Biol. 2013;94(4):711-721.
40. Ferreira MC, Whibley N, Mamo AJ, Siebenlist U, Chan YR, Gaffen SL. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun. 2014;82(3):1030-1035.
41. Roes J, Choi BK, Power D, Xu P, Segal AW. Granulocyte function in grancalcin-deficient mice. Mol Cell Biol. 2003;23(3):826-830.
42. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004; 23(7): 635-641.